Documents

Discussions Technicals Forecast Seasonals

Chemomab Therapeutics Ltd. Sponsored ADR SEC filings and other documents

Explore the latest company documents and SEC filings from Chemomab Therapeutics Ltd. Sponsored ADR, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q1 2025

May 15, 2025

Earnings release8-K

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 11, 2025

Transcript

2024

Q4 2024

Mar 03, 2025

Annual report20-F

Earnings release8-K

Q3 2024

Nov 14, 2024

Earnings release8-K

Q2 2024

Aug 21, 2024

Earnings release8-K

Study Result

Jul 25, 2024

Slides

Press release

Q1 2024

May 09, 2024

Earnings release8-K

2023

Q4 2023

Mar 07, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 09, 2023

Earnings release8-K

Q2 2023

Aug 14, 2023

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 20, 2023

Annual report10-K

Q3 2022

Nov 11, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 12, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 12, 2022

Quarterly report10-Q

Earnings release8-K